Noronex Limited has updated its corporate governance policies, focusing on whistleblower protection and anti-bribery measures, as well as its commitment to ethical business practices and risk management.
Material actions and disclosures
The company has disclosed its whistleblower policy and anti-bribery and anti-corruption policy on its website. Any material breaches of these policies are reported to the Board or a committee of the Board.
Noronex Limited also disclosed its commitment to conducting all business activities fairly, honestly, and with a high level of integrity, in compliance with all applicable laws, rules, and regulations.
The company has completed periodic reviews of its risk management framework in accordance with the applicable processes.
Forward commitments
Given the current small size of the Board and the Company’s operations, Noronex Limited does not intend to set measurable gender diversity objectives at this time. The Board will consider the application of measurable diversity objectives if it becomes necessary to appoint new Directors or senior executives.
Noronex Limited will disclose whether it has any potential or apparent exposure to environmental or social risks and, if it does, put in place management systems, practices, and procedures to manage those risks.
Attributed to the Company’s Corporate Governance Statement.